dr. robert on the phase iii combi-v study in braf-mutant melanoma
Published 7 years ago • 287 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:33
dr. robert on next steps following the phase iii combi-v study in melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
2:12
phase iii combi-d study of dabrafenib and trametinib in patients with melanoma
-
1:19
dr. robert on potential of dabrafenib/trametinib in melanoma brain metastases
-
1:17
dr. dummer on combi-ad trial results in braf-mutant melanoma
-
3:06
combi-d: phase 3 trial of dabrafenib plus trametinib in braf v600e/k-mutated melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
1:46
dr. nathan on 5-year survival outcomes of combi-d and combi-v trials in braf v600-mutant melanoma
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma
-
1:42
dr. jason luke describes results from the phase iii combi-d trial
-
2:11
dr. georgina long on dabrafenib and trametinib in braf-mutated melanoma
-
1:26
dr. nathan on long-term outcomes with dabrafenib/trametinib in braf v600-mutant melanoma
-
1:36
dr. weber on combination strategies for braf-mutant melanoma
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
7:01
dual-targeted therapy for braf-mutant melanoma
-
4:24
dabrafenib/trametinib/pembrolizumab for advanced melanoma: update from keynote-022